Amazon.com (NASDAQ:AMZN): Bernstein, expecting Amazon’s 2014 gross profit margins to significantly beat projections, recommends the stock for longer-term investors. The firm also expects the company’s EBITDA and operating income to exceed expectations over the longer term, and it keeps a $350 price target and Outperform rating on the stock.
Maxim Integrated (NASDAQ:MXIM): A trip to Korea and cautious commentary regarding Samsung Q3 units was enough to lead Susquehanna to downgrade the shares from Positive to Neutral, and lower its price target to $30 from $37.
Pandora Media (NYSE:P): While Apple’s (NASDAQ:AAPL) release of iTunes Radio will put pressure on Pandora, RBC Capital thinks that some of the impact from the new service may already be priced into Pandora’s stock, and it notes that Pandora’s service has more potential reach because it is available on platforms other than Apple. The firm keeps an Outperform rating on the radio streaming service.
Actavis Pharmaceuticals (NYSE:ACT): JPMorgan has put Actavis on its Analyst Focus List, citing earnings growth potential following the acquisition of Warner Chilcott. The firm has an Overweight rating on the stock, with a $150 price target.
Don’t Miss: AmazonFresh Has Arrived on LA’s Doorstep.